Central retinal vein occlusion associated with the polycystic ovarian syndrome

International Journal of Clinical Practice

Volumn 51, Issue 5, 1997, Pages 339-341

  Salzmann, J ^a,b   Jagger, J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; DISEASE ASSOCIATION; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; POLYCYSTIC OVARY SYNDROME; RETINAL VEIN OCCLUSION;

EID: 0030880106     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979; 86: 1931-1939.
2. McGrath MA, Wechsler F, Hunyor AB, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978; 138: 216-220.
3. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990; 97: 1543-1548.
4. Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology 1983; 90: 481-483.
5. Dodson PM, Kritzinger EE. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 1985; 104: 114-119.
6. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981; 1: 27-55.
7. Quinlan P, Elman MJ, Bhatt AK et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110: 118-123.
8. Gonder JR, Magargal LE, Walsh PN et al. Central retinal vein associated with mitral valve prolapse. Can J Ophthalmol 1983; 18: 220-222.
9. Chizek DJ, Franceschetti AT. Oral contraceptives: their side-effects and ophthalmological manifestations. Surv Ophthalmol 1969; 14: 90-105.
10. Stowe GC III, Zakov ZN, Albert DM. Central retinal vein occlusion associated with oral contraceptives. Am J Ophthalmol 1978; 86: 798-801.
11. Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 1963; 14: 631-641.
12. Yen SSC. The polycystic ovary syndrome. Clin Endocrinol 1980; 12: 177-208.
13. Rebar RW. Hirsutism, hyperandrogenism and polycystic ovarian syndrome. In: DeGroot LJ, Ed. Endocrinology 2nd ed. Philadelphia: WB Saunders, 1989; vol 3.
14. Farquhar CM, Birdsall M, Manning P et al. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynecol 1994; 34(1): 67-72.
15. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; i: 870-872.
16. Clayton RN, Ogden V, Hodgkinsson J et al. How common are polycystic ovaries and what is their significance for the fertility of the population? Clin Endocrinol 1992; 37: 127-134.
17. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 355-359.
18. Magargal LE, Gonder JR, Maher V. Central retinal vein occlusion in the young adult. Trans PA Acad Ophthalmol Otolaryngol 1985; 37: 143-153.
19. Fong ACO, Schatz H, MacDonald HR et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina 1992; 12: 3-11.
20. Schiff E, Peleg E, Goldenberg M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high-risk pregnancies. N Engl J Med 1989; 321: 351-356.